Profusa, Inc.


Monitoring tissue oxygen in peripheral arterial disease

Cardiology Medical Devices Digital Medical Devices

Do you know anyone using Lumee™?

Lumee™ Oxygen Platform is CE Marked for use in the European Union and all countries that accept the CE Mark. Caution: Investigational Device Limited by Federal (or the United States) Law to Investigational Use.

Profusas first clinical offering, the Lumee™ Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. Potential applications include monitoring of compromised tissue, such as peripheral artery disease.

In the European Union, the Lumee™ Oxygen Platform may help salvage limbs by providing the medical practitioner with a new way to continuously measure tissue oxygen levels in the ischemic limb before, during, and after treatment, enabling appropriate therapy to be administered in a timely fashion before advanced symptoms appear.


Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2023 Netspective Media LLC. All Rights Reserved.

Built on Feb 3, 2023 at 6:31am